A1 protein is one of the major pre-mRNA/mRNA binding proteins in eukaryotic cells and one of the most abundant proteins in the nucleus. It is localized to the nucleoplasm and it also shuttles between the nucleus and the cytoplasm, The amino acid sequence of A1 contains two RNP motif RNA-binding domains (RBDs) at the amino terminus and a glycine-rich domain at the carboxyl terminus. This configuration, designated 2 × RBD-Gly, is representative of perhaps the largest family of hnRNP proteins. Unlike most nuclear proteins characterized so far, A1 (and most 2x RBD-GIy proteins) does not contain a recognizable nuclear localization signal (NLS). We have found that a segment of ca. 40 amino acids near the carboxyl end of the protein (designated M9) is necessary and sufficient for nuclear localization; attaching this segment to the bacterial protein B-galactosidase or to pyruvate kinase completely localized these otherwise cytoplasmic proteins to the nucleus. The RBDs and another RNA binding motif found in the glycine-rich domain, the RGG box, are not required for A1 nuclear localization. M9 is a novel type of nuclear localization domain as it does not contain sequences similar to classical basic-type NLS. Interestingly, sequences similar to M9 are found in other nuclear RNA-binding proteins including hnRNP A2.
A1 protein is one of the major pre-mRNA/mRNA binding proteins in eukaryotic cells and one of the most abundant proteins in the nucleus. It is localized to the nucleoplasm and it also shuttles between the nucleus and the cytoplasm, The amino acid sequence of A1 contains two RNP motif RNA-binding domains (RBDs) at the amino terminus and a glycine-rich domain at the carboxyl terminus. This configuration, designated 2 × RBD-Gly, is representative of perhaps the largest family of hnRNP proteins. Unlike most nuclear proteins characterized so far, A1 (and most 2x RBD-GIy proteins) does not contain a recognizable nuclear localization signal (NLS). We have found that a segment of ca. 40 amino acids near the carboxyl end of the protein (designated M9) is necessary and sufficient for nuclear localization; attaching this segment to the bacterial protein B-galactosidase or to pyruvate kinase completely localized these otherwise cytoplasmic proteins to the nucleus. The RBDs and another RNA binding motif found in the glycine-rich domain, the RGG box, are not required for A1 nuclear localization. M9 is a novel type of nuclear localization domain as it does not contain sequences similar to classical basic-type NLS. Interestingly, sequences similar to M9 are found in other nuclear RNA-binding proteins including hnRNP A2.
T HE heterogeneous nuclear RNP (hnRNP) ~ A1 protein is an abundant nuclear protein and is one of the major pre-mRNA binding proteins ; reviewed in Cobianchi et al., 1990; . A1 binds with high affinity to sequences that resemble premRNA 3' and 5' splice sites Burd and Dreyfuss, 1994a) . A1 has an effect on alternative splicing in vitro and in vivo as the amount of A1 relative to that of the splicing factor SF2/ASF determines the utilization of alternative 5' splice sites Fu et al., 1992; C~tceres et al., 1994; Yang et al., 1994) , although it does not seem to be essential for constitutive splicing (Ben-David et al., 1992) . One of the most intriguing properties of A1 is its cellular localization and transport. A1 is a nuclear protein but it is not confined to the nucleus, rather it shuttles between the nucleus and the cytoplasm (Pifiol-Roma and Dreyfuss, 1992) . Furthermore, its nuclear 1. Abbreviations used in this paper: Gly, glycine; HA, hemaglutinin; hnRNP, heterogeneous nuclear RNP; HPABP, human poly(A)-tail mRNA binding protein; NLS, nuclear localization signal; PCR, polymerase chain reaction; PK, pyruvate kinase; polII, polymerase II; RBD, RNA-binding domains.
localization requires RNA polymerase II (POlID transcription since in the absence of polII transcrpfion A1 that is exported from the nucleus remains in the cytoplasm (PifiolRoma and Dreyfuss, 1991; Pifiol-Roma and Dreyfuss, 1992; Pifiol-Roma and Dreyfuss, 1993) . By immunofluorescence microscopy, A1 is detected only in the nucleus, presumably because the return of A1 to the nucleus is normally very rapid. While in the cytoplasm A1 can bind mRNA, and therefore it is likely to have functions in the cytoplasm (e.g., in mRNA localization and stability), and it may alsoplay an important role in the transport of mRNA from the nucleus to the cytoplasm. Importantly, recent findings indicate that this pattern of localization and transport is not unique to A1, but is found for many of the other pre-mRNA binding proteins (Pifiol-Roma, S., and G. Dreyfuss, unpublished results). The amino acid sequence of A1 from mammals and amphibians has been determined (Williams et al., 1985; Cobianchi et al., 1988; Buvoli et al., 1988; Kay et al., 1990; Good et al., 1993) and it contains two RNP motif RNAbinding domains (RBDs; Dreyfuss et al., 1988; Bandziulis et all, 1989; Kenan et al., 1991; Burd and Dreyfuss, 1994b) at the amino terminus and a glycine-rich domain at the carboxyl terminus. This structure, designated 2x RBD-Gly, is representative of perhaps the largest family of hnRNP proteins (Matunls et al., 1992; Burd and Dreyfuss, 1994b) . A1 also contains another motif found in many RNA-binding proteins, an arginlne-and glycine-rich domain that contains a cluster of the tripeptide repeat and termed the RGG box (Kiledjian and Dreyfuss, 1992) . This motif has been demonstrated to have RNA binding activity (Kilejian and Dreyfuss, 1992) . Unlike most nuclear proteins characterized so far, the A and B group hnRNP proteins do not contain recognizable nuclear localization signals (NLSs) which generally resemble either the single basic domain SV-40 large T-antigen NLS (Kalderon et al., 1984;  for review see Nigg, 1990) or the double basic (bipartite) domain nucleoplasmin NLS (Robbins et al., 1991; reviewed in Dingwall and Laskey, 1991) . However, other hnRNP proteins, such as the C group and U proteins, contain candidate NLSs. It is likely that the C group and U proteins are imported to the nucleus by mechanisms similar to those used by other nuclear proteins that contain similar basic NLSs. On the other hand, the mechanism and pathway of the nuclear import of the A and B group proteins may be different from those used by other nuclear proteins that contain classical types of NLSs. We therefore set out to determine the sequence within A1 that localizes it to the nucleus. Here we report that a sequence of the carboxyl terminus of A1 is necessary and sufficient for the nuclear localization of this protein and it can completely localize a large heterologous bacterial protein, ~-galactosidase, the cytoplasmic enzyme pyruvate kinase, and the mRNA poly(A)-binding protein to the nucleus. Interestingly, similar sequences to the nuclear localization domain of A1 are found in several other nuclear RNA-binding proteins including A2, and the sequence is highly conserved in vertebrates as Xenopus laevis ALIA2 proteins contain a similar domain.
Materials and Methods

Plasmid Constructions
The eDNA encoding human hnRNP A1 (pBSO1; Buvoli et al., 1990 ) was a kind gift from Dr. Silvano Riva (CNR, Pavia, Italy). cDNAs encoding human hnRNP Cl and mRNA poly(A)-binding protein (HPABP) were described previously (Swanson et al., 1987; C-6riach et al., 1994a) . Epitope tagging of hnRNP AI, hnRNP CI, and HPABP was performed as described by Koludziej and Young (1991) using the eukaryotic expression vector pHHSI (Siomi et al., 1993) which was derived from pcDNA I (Invitrogen San Diego, CA) by insertion ofa 72-bp BstXI fragment encoding a 9-amino acid epitope from the influenza virus hemaglutinin (HA) protein with an initiator methionine followed by Sal I and EcoRI restriction sites. The HA epitope for the 12C.A5 anti-HA monoclonal antibody (Niman et al., 1983) was placed at the N-termini of all constructs.
HA-tagged hnRNP A1 with the entire protein-coding region (wild-type) was constructed using the polymerase chain reaction (PCR). A 34-base synthetic single-stranded DNA PCR primer (5'-A1) that included 9 bases to cream a SalI site and 25 bases complementary to positions +1 through +25 was synthesized. The 5 '-AI primer, in conjunction with a primer (3 '-A1) that included 9 bases to create NotI site and 25 bases complementary to the sequence encoding the carboxyl terminal end of hnRNP A1, was used to prime a PCR using plasmid pBSO1 as template DNA. The amplified fragment was digested with SalI and Not and ligated into SalLNotI-digested pHHSI, resulting in plasmid pl6FA1. The NH2-terminal deletion mutants Nd97, Ndll2, Nd149, Nd155, and Nd186 were also generated by PCR using primers that included 9 bases to create a SalI site and 25 bases complementary to the positions indicated and a primer 3'-A1. The COOH-terminal deletion mutants of hnRNP Al were constructed as follows: plasmid pl6FA1 was digested at its unique NotI site, and then exonuclease III and SI nuclease digestion (Guo and Wu, 1983; Siomi et al., 1990) were performed to create deletions in the 3' portion of the hnRNP AI coding region using doublestranded nested deletion kit (Pharrnacia, Piscataway, NJ). After nuclease digestion, a synthetic Hpd linker (TTAAGTrAACTTAA; Pharmacia) was ligated at the terminus. Deletion fragments were then digested with Hpal and Sail, and inserted into pHHSI that had been digested with Notl and treated with Klenow fragment to create blunt end and then digested with SalI. To determine exact nucleotide endpoints, clones were sequenced using T3 primer.
HA-tagged wild-type hnRNP C1 and its NH2-terndnal deletion (Nd87) were generated by PCR as described above for hnRNP AI constructs. Synthetic 5' PCR primers that included a SalI site and 25 bases complementary to sequences encoding the NH2-terminal end of hnRNP C1 and the NH2-terminal end of the auxiliary domain, in conjunction with a 3' primer that included a NotI site and 25 bases complementary to the sequence encoding the carboxyl terminal end of hnRNP C1, were used to prime PCRs using plasmid pHC12 (Swanson et al., 1987) as template DNA. The amplified fragments were digested with SalI and NotI and ligated into SalI-NotI-digested pHHSI, resulting in plasmids pl6FC1 and p16Nd87, respectively. The COOH-terminal deletion mutants of hnRNP CI were constructed using plasmid pl6FC1 as described for hnRNP Al deletions.
HA-tagged wild-type HPABP (G6rlach et al., 1994a) was constructed using PCR-generated fragment as described above. PABP4 × RBDs was also PCR-generated using the 5'primer that included a SalI site and 25 bases complementary to positions +1 through +25 and the 3' primer that included NotI site, a termination codon and 25 bases complementary to the sequence encoding the end of the four RNA-binding domains. PABP-Gly was also generated by PCR in several steps involving an overlap extension protocol (Horton et al., 1990) .
The ~-galactosidase expression vector (pl6/~-Gal) was constructed by inserting a HindlII-BamHI fragment from pCHI10 (Hall et al., 1983 : Clontech, Palo Alto, CA) into pcDNAI that has been digested with HindlII and BamI-II. ~-Gal Al and/3-Gal M1 were PCR-generated by annealing a primer carrying, in series, a EcoRI site and 20 bases corresponding to the human hnRNP A1 eDNA (pBSO1) and a 3' primer (3'-Al). The amplified fragments were digested with EcoRI and Not and ligated into EcoRI-NotI-digested pl6/3-GaiA1./~-Gal M2 to M4 were constructed as follows; plasmid pl6~-GalA1 was digested at its unique EcoRI site, and then treated with nucleases as described for hnRNP A1 deletions. After nuclease digestion, a synthetic EcoRI linker (GGAATTCC) was ligated at the terminus. Deletion fragments were then digested with EcoRI and Notl, and inserted into pl6~-Gal that has been digested with EcoRI and Not. To determine the exact nucleotide endpoints, clones were sequenced using a primer of 20 nucleotides spanning the region 50-70 nucleotides upstream of the EcoRI site of the lacZ gene. /~-Gal M5 to M8 were constructed as described for hnRNP Al COOHterminal deletion mutants.
Myc-tagged pyruvate kinase (PK)-A1 fusions were constructed as follows: synthetic 5' PCR primer that included an EcoRI site which correspends to codon 12 of chicken muscle pyruvate kinase, in conjunction with a 3' primer that included a Not site and 25 bases complementary to the sequence encoding the carboxyl terminal end of PK, were used to prime PCR using the PK eDNA-containing plasmid, RLPK (a gift from Dr. William Lee, University of Pennsylvania, Philadelphia, PA; Dang and Lee, 1988) as template DNA. The amplified fragment was digested with EcoRI and Not and ligated into EcoRI-NotI-digested pcDNA3 (Invitrogen). The resulting plasmid containing PK eDNA under the control of the CMV early promoter was cut at the BstXI and EcoRI sites and iigated to a doublestranded oligonucleotide encoding the peptide sequence MEQKLISEEDL to create an epitope tag at the amino terminus. This sequence is the epitope for the 9El0 anti-myc monoclonal antibody (Evan et al., 1985) . TO fuse portions of Al to the 3' end of the PK eDNA, we generated various KpnINofl fragments of Al by PCR as described above. These KpnI-NotI fragments were subcloned into the KpnI and NotI sites of the myc-tagged pcDNA3-PK. The KpnI site corresponds to codon 443 of PK (Roberts et al., 1987; Dang and Lee, 1988) .
Cell Culture and Transfection
Monkey kidney COS-1 cells were grown in Dulbecco's modified Eagle's medium (DME; GIBCO BRL, Galthersburg, MD) supplemented with 10 % FCS (GIBCO BRL). Cells grown on glass coverslips in 30 nun dishes were transfected with 5/zg DNA (all plasmids were purified by Cs-EtBr density gradient centrifugation) by the calcium phosphate co-precipitation technique with the following modifications: a total of 5/~g of plasmid DNA was added to 250 ml of Hepes-buifered saline (140 mM NaCI, 1.5 mM Na2HPO4, 25 mM Hepes, pH 7.05) and precipitated by adding 16.5 pl of 2 M CaCI2 with constant stirring. After incubating the cells with the coprecipitate for 4-5 h, cultures were washed twice with 2 ml DME (without FCS), and then were incubated with fresh DME and FCS. Cells were fixed for immunofluorescence assays 48 h after transfection. The predicted amino acid sequence at and around the putative nuclear localization sequence of the hnRNP C1 is shown. The amino acid sequences similar to a bipartite NLS motif are underlined. COS1 cells were transfected with plasmids encoding the HA-tagged wild-type hnRNP C1 and its deletions, and the subcellular distribution of the proteins was determined 48 h later by indirect immunofluorescence using the anti-HA monoclonal antibody (12CA5) as detailed in Materials and Methods. Cells exhibited either nuclear and cytoplasmic (N/C) or nuclear (N) fluorescence.
lmmunofluorescence Microscopy
Indirect immunofluorescence analysis was carried out as described for human HeLa cells (Choi and Dreyfuss, 1984) with the following modifications: cells were fixed with 2% formaldehyde (Polysciences, Warrington, PA) in PBS for 30 min at room temperature followed by 3 min in acetone at -20°C. Anti-HA tag staining was performed by incubation for 1 h at room temperature with 1:1,500 12CA5 anti-HA mAb (ascites fluid diluted in PBS with 3 % BSA). Cells were then washed three times with PBS and incubated for 1 h at room temperature with 1:1,500 fluorescein-conjngated anti-mouse antibody (Cappel Laboratories, Cochranville, PA) in PBS containing 3 % BSA. After washing three times, coverslips were inverted and mounted on glass microscope slides. Anti-~-galactosidase staining was using mouse monoclonal antibody to F~cherichia coli ~-galactosidase (Boehringer Mannheim Biochemicals, Indianapolis, IN; 1:1,500 in PBS with 3% BSA) as the primary antibody. Immunottuorescent visualization of the PK-A1 fusion proteins was achieved in an identical manner to that of the 12CA5 antibody using a monoclonal anti-m3~ 9El0 antibody (1:1,500 dilution in PBS with 3 % BSA).
Siomi and Dreyfuss Nuclear Localization of hnRNP AI 
Gel Electrophoresis and Immunoblotting
COS-1 cells were transfected with 10/~g plasmid DNA per 30 mm petri dish as described above. Cells were harvested 48 h after transfection by scraping in SDS sample buffer. Samples were separated on a 12% SDS-polyacrylamide gel and electrotransferred to nitrocellulose membrane as described previously (Siomi et al., 1993) . The membrane was blocked with 5% dried milk powder in PBS for 1 h, 9El0 anti-myc tag antibody (1:1,500 ascites fluid) was added and incubated for additional 1 h at room temperature. After five washes in PBS with 0.05% NP-40, the blot was incubated with peroxidase-conjugated goat anti-mouse IgG (Jackson Immuno Research Laboratories, 1:10,000) for 1 h at room temperature, washed five times in PBS/0.05 % NP-40, and developed with an enhanced chemiluminescence Western blotting detection system (Amersham International, Buckinghamshire, UK).
Results
To determine the sequence in A1 that localizes it to the nu- cleus, parts of A1 were cloned as fusion proteins with the influenza HA peptide (Kolodziej and Young, 1991) at the amino terminus to provide an epitope tag for detection of the expressed polypeptides in transfected cells by immunofluorescence microscopy. All the constructs were confirmed by DNA sequencing and expression of proteins of the expected size, amount, and immunologic reactivity were confirmed by immunoblotting. For reference, we carried out similar experiments on the hnRNP C1 protein which contains a candidate bipartite basic NLS (amino acids 144 to 157). As expected, the entire C1 protein fused to HA localized entirely to the nucleus (Fig. 1) . Amino terminal deletion of the RNA-binding domain of hnRNP C1 (G6rlach et al., 1994b) showed that the carboxyl terminal auxiliary domain by itself, Nd87, localized to the nucleus. Thus the RNAbinding activity of C1 is not required for its nuclear localization. Carboxyl terminal deletions indicated that the sequence between amino acids 145 and 175 are necessary for nuclear localization, in good agreement with NLS deduced from the protein sequence.
The Carboxyl Terminal Region of hnRNP A1 Contains the Determinant for Nuclear Localization
HnRNP A1 is distinguished from most other nuclear proteins by the absence of a short, highly basic nuclear localization sequence and by its transcription-dependent nuclear localization (reviewed in Pifiol-Roma and Drefuss, 1993). To identify the regions of A1 important for nuclear localization, we constructed a series of amino terminal and carboxyl terminal deletions. The primary sequence of wild-type A1 is shown schematically in Fig. 2 B and Fig. 6 . The major characteristics of this protein are two RNA-binding domains within the amino terminus, a stretch rich in glycine and arginine residues (RGG box: Kiledjian and Dreyfuss, 1992) in the central region, and a glycine-rich (Gly) domain at the carboxyl terminus. Like hnRNP C1, the entire hnRNP A1 protein tagged with HA also completely localized to the nucleus (Fig. 2) . The carboxyl domain by itself (Nd97 to Nd186) also showed exclusively nuclear staining but the two amino terminal RBDs (Cd142), which efficiently bind RNA (data not shown; Riva et al., 1986; Cobianchi et al., 1990) , and all other carboxyl terminal deletions did not localize to the nucleus (Fig. 2) . We therefore, concluded that the nuclear localizing sequence of A1 resides in the carboxyl part (Gly domain) of the protein.
Further evidence that the RBDs of A1 have no role in the localization of A1 to the nucleus and that the Gly domain of A1 is sufficient for nuclear localization was obtained by constructing a human poly(A)-tail mRNA binding protein (HPABP; G6dach et al., 1994a ) that contains the A1 Gly domain instead of the normal, proline-rich carboxyl domain (Adam et al., 1986; Sachs et al., 1986) , (Fig. 3) . HA-tagged PABP is localized to the cytoplasm and appears to be excluded from the nucleus (Fig. 3) . This distribution is identical to that of endogenous PABP (G6rlach et al., 1994a) . Deletion of the proline-rich carboxyl domain of PABP (4x RBDs) causes a mixed distribution such that a proportion of the cells show nuclear fluorescence (this may reflect the distribution of poly(A) RNAs), suggesting that the proline-rich auxiliary domain may be responsible for cytoplasmic confinement of PABP. The fusion protein between the four RBDs of PABP and the Gly domain of A1 is localized to the nucleus in contrast to the wild-type and proline-rich car-boxyl domain-deleted PABP (4x RBDs) (Fig. 3) . This experiment also demonstrated the capacity of the A1 Gly domain to localize to the nucleus other RBDs than those found in A1, and a heterologous protein larger than A1.
A Domain in the Carboxyl Region of A1 Localizes Heterologous Proteins to the Nucleus
To further delineate the sequence responsible for the nuclear localization of A1 and to obviate the concern of diffusion of small proteins into the nucleus, we fused the A1 glycine-rich carboxyl domain and parts of it to /3-galactosidase (Mr 116,000) and carried out transfection experiments and de- The chimeric proteins contain a constant portion of B-galactosidase at the amino terminus and the entire A1 or its deleted sequences at the carboxyl terminus, fl-Galactosidase is represented by the hatched box. Numbers at the fusion points between B-galactosidase and hnRNP AI portions indicate amino terminal amino acid positions of hnRNP A1 moieties. The/3-galaetosidase portion in the fusion proteins consists of 1004 residues. Assessment of the fluorescence staining was as described in the legends to Figs. 1-4 . The symbol N>C refers to predominantly nuclear staining accompanied by some cytoplasmic staining.
tected the expressed proteins with anti-fl-galactosidase antibodies. Bacterial /3-galactosidase is a well-characterized reporter for nuclear localization (Btirglin and De Robertis, 1987; Siomi et al., 1988 ; see also Silver, 1991 for review). fl-gal-A1 completely localized to the nucleus whereas /3-galactosidase by itself was mostly cytoplasmic (Fig. 4) . These data suggest that nuclear import of A1 is an active transport because the size of the fusion protein is well beyond the reported diffusion limit for the nuclear pores (Dworetzky et al., 1988; Peters, 1986) . The Gly domain and amino terminal deleted portions of this domain up to amino acid residue 252 (Fig. 4) , act as targeting signals capable of directing A series of fusion constructs similar to those described in Fig. 4 were constructed using chicken muscle pyruvate kinase in place of B-galactosidase. Note that the constructs were made using the KpnI site in PK which truncates the protein at amino acid 443, hence, PK-M series of constructs are slightly smaller than WT PK. The myc epitope was placed at the NH2 termini of all constructs. (Cobianchi et ai., 1988) ; human hnRNP A2 (Burd et al., 1989) ; Xenopus bnRNP A1 and A2 (Good et al., 1993) . /~-gal to the nucleus. ~Gal-M4, however, has some cytoplasmic staining. The fusion proteins with the carboxyl-terminal deletions caused a decrease in the efficiency of nuclear targeting (data not shown) as expected from the results of carboxyl terminal deletions of HA-A1. The ~-galactosidase fusion proteins clearly demonstrate the ability of a small portion of the carboxyl region of A1 to confer nuclear accumulation of a large heterologous protein that is normally found in the cytoplasm.
The Region of A1 Which Is Necessary and SujOicient for Nuclear Import Comprises a 40-Amino Acid Domain Near the Carboxyl Region of the Protein
We wished to define further the sequences within the carboxyl portion of A1 that are necessary for its nuclear localization. The last 60 amino acids of A1 have been shown above to be sufficient to localize E. coli O-galactosidase to the nucleus. However, the results of Kalderon et al. (1984) have questioned the suitability of this protein as a reporter for nuclear localization sequences; despite its large size and bacterial origin, E. coli/3-galactosidase may be able to parflatly localize to the nucleus of some eukaryotic cells. Thus, this bacterial protein may contain a partially functional NLS.
In order to avoid this possibility, we constructed gene fusions between portions of A1 and chicken muscle pyruvate kinase eDNA, whose encoded protein is stable and excluded from the cell nucleus (Kalderon et al., 1984; Richardson et al., 1986) . Portions o r a l were fused to the 3' end of the myctagged PK eDNA (Fig. 5) . Each gene fusion was expressed in COS-1 cells, and immunoblotting analysis demonstrated that a protein of the predicted sized was produced, and little, if any, degradation was apparent (Fig. 5) .
Fusion proteins with NH2-terminal deletions up to residue 252 (PK-M4) were nuclear in localization as judged by immunofluorescence with anti-myc antibody, supporting the data obtained with/3-galactosidase fusion experiments. Pyruvate kinase bearing the M4 portion of A1 appears to be more completely localized to the nucleus than is ~-galactosidase, for reasons we do not understand. Further deletions resulted in a protein (PK-M5) which was also completely localized to the nucleus. It should be noted that the fusion proteins showing nuclear localization, except PK-wild type A1 fusion, showed nonhomogeneous nuclear accumulation in some cells.
Fusion proteins with carboxyl terminal deletions demonstrated that while the last 15 amino acids of the protein (PK-M6 and PK-M9) were not essential for nuclear localization, further deletions resulted in A1 fusion proteins that were no longer completely localized to the nucleus. From these experiments, we conclude that the amino acids comprising M9 (boxed sequence in Fig. 6 ) are necessary and sufficient for complete nuclear localization of a heterologous protein that is otherwise cytoplasmic. It is possible that a few additional amino acids at the amino and carboxyl ends of M9 can also be removed without loss of nuclear localization, as we have not carried out further single amino acid deletions.
Discussion
By transfection of DNAs encoding epitope-tagged cytoplasmic proteins fused to portions of A1 and using an immunofluorescence microscopy assay we have found that a segment of 40 amino acids near the carboxyl terminus of A1 is necessary and sufficient for nuclear localization. HnRNP A1 and C1 differ in the requirements for their nuclear localization; A1 requires ongoing RNA polII transcription for nuclear localization whereas C1 does not. This suggests that a mechanistic difference exists concerning the subcellular trafficking of these hnRNP proteins (Pifiol-Roma and Dreyfuss, 1993). Nuclear entry of hnRNP C1 is mediated by the well characterized NLS pathway whereas nuclear localization of hnRNP A1 occurs by a novel mechanism.
The assay for nuclear localization of a series of hnRNP A1 deletions and fusions to/~-galactosidase and pyruvate kinase determined that neither the two RBDs nor an RGG box, the two types of RNA-binding elements which were previously found to mediate the RNA-binding activity of this protein, are required for nuclear localization. The results from the fusion of carboxyl terminal hnRNP A1 fragments to pyruvate kinase demonstrate that the sequences spanning the region from amino acids 264 to 305 are responsible for nuclear localization of hnRNP A1. This segment of A1 (termed M9, Fig. 6 ) does not contain any short basic stretches similar to the basic type NLS previously identified in large T of SV-40 or a bipartite NLS previously found in nucleoplasmin (for reviews see Nigg, 1990; Forbes, 1992) and therefore is a novel type of nuclear localization sequence. The results of a search for proteins containing regions of similarity to the nuclear localization domain of hnRNP A1 are presented in Fig. 6 . Similar amino acid sequences are found in the hnRNP A/B groups from mammals and amphibians.
Thus far, two other proteins whose nuclear localization is mediated by unusually large sequences rather than short basic NLSs have been described, namely the trans-acting protein Tax of human T-cell leukemia virus type I (Smith and Greene, 1992) and the snRNP protein UIA (Kambach and Mattaj, 1992) . Neither of these have significant sequence similarity to the NLS of hnRNP A1. The U1A NLS is very large (more than 100 amino acids) but does contain several basic amino acid clusters which bear a resemblance to the SV-40 T antigen class of NLSs. In the case of Tax, the amino terminal 48 residues comprise a functional NLS which contains a zinc finger-like cysteine-rich sequence.
Specific protein-protein interactions have been shown to contribute to the nuclear localization of several proteins including adenovirus encoded DNA polymerase (Zhao and Padmanabhan, 1988 ) and the pancreas-specific transcription factor PTF1 (Sommer et al., 1991). It is possible that hnRNP A1 could be transported to the nucleus by complex formation through the Gly domain with a protein that contains a classical NLS (piggyback transport). Alternatively, hnRNP A1 protein may be targeted to the nucleus by a mechanism independent of that which targets classical NLS-bearing proteins. The import of m3GpppN-containing snRNPs is kinetically non-competitive with the SV-40 T-antigen-like import pathway (Fischer and Lithrmann, 1990 ; reviewed in Goldfarb and Michaud, 1991), suggesting that multiple nuclear targeting mechanisms exist. It will be of interest to test whether free m3GpppG dinucleotide and/or T-antigen NLS peptide compete nuclear import of hnRNP A1. Whether the components of the classical NLS pathway for nuclear import are used by hnRNP A1 or not, it is clear that some component(s) of the A1 import pathway is unique, since A1 import is dependent on RNA pollI transcription. Furthermore, it is possible that A1 import is subject to different regulatory mechanisms than classical basic NLS-bearing protein import.
It has been shown that ImRNP A1 shuttles between the nucleus and cytoplasm and can be cross-linked to mRNA in the cytoplasm (Pifiol-Roma and Dreyfuss, 1992, 1993), suggesting that a mechanism exists that regulates the nuclear reaccumulation of hnRNP A1 by, for example, monitoring the release of the mRNAs in the cytoplasm. Identifying the components of the transport machinery with which the nuclear localization domain of hnRNP A1 interacts will be important for determining the mechanism of transcription-dependent localization of RNA-binding proteins and of the nucleo-cytoplasmic shuttling of these proteins.
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